To The Moon

$ASTS 20261016 45.0 PUT$ Limit order filled to strangle existing ASTS naked calls for credit.

$HOOD 20261023 121.0 CALL$ Limit order filled during Hood price recovery to sell call at strike $121

$ASTS 20261023 40.0 PUT$ Limit order filled during capitulation to sell ASTS cash secured put at $40 psychological support.

$TMF DIAGONAL 261016/261030 PUT 26.5/PUT 26.0$ Diagonal roll to lower strike and delay options expiry whilst pocketing some credit.

$TMF CALENDAR 261023/261106 PUT 31.0/PUT 31.0$ Delay option expiry by one week and collect a little credit at the same time.

$INTC 20261016 96.0 PUT$ Limit order filled to sell INTC cash secured put below $100 psychological support for credit.

$INTC DIAGONAL 261012/261009 PUT 103.0/PUT 105.0$ Diagonal roll put to delay assignment by one week and lower strike plus collect credit as a bonus.

$AMZN VERTICAL 261030 PUT 245.0/PUT 240.0$ 1️⃣ Why am I making this trade now? Bull put spread 30th Oct expiry with strike $245/240. Catching the upside momentum. The older BPS for 23rd expiry was closed on Fri and assessed the setup is still viable so opened another trade 1 week later to 30th Oct.  Since the price had moved up by at least $10 between the 2 trades, I've adjusted up the stroked by a $5 higher to short put at $245 and long put 1 strike lower.  Stock still a distance away from short term high so it the Q4 positive momentum market can carry the trade, then this can be profitable.  2️⃣ What’s my plan from here? take profit at around 70-90% max premium. Take

ARKK Investment Tracker position change: Increased position in Eli Lilly by 7,614 shares, the number of shares held increased 20.17% compared to the previous period and now represents 0.52% of the total position.

ARKK Investment Tracker position change: Increased position in Pacific Biosciences of California by 3,466,908 shares, the number of shares held increased 20.33% compared to the previous period and now represents 0.54% of the total position.

ARKK Investment Tracker position change: Increased position in SoFi Technologies Inc. by 603,621 shares, the number of shares held increased 20.32% compared to the previous period and now represents 0.54% of the total position.

ARKK Investment Tracker position change: Increased position in Kratos Defense & Security Solutions by 605,730 shares, the number of shares held increased 31.06% compared to the previous period and now represents 1.04% of the total position.

ARKK Investment Tracker position change: Increased position in GeneDx Holdings by 258,030 shares, the number of shares held increased 20.32% compared to the previous period and now represents 1.02% of the total position.

ARKK Investment Tracker position change: Increased position in X-Energy by 1,243,620 shares, the number of shares held increased 20.33% compared to the previous period and now represents 1.03% of the total position.

$HIMS 20261030 40.0 CALL$ Recent news balance for Hims & Hers Health (HIMS) watchlist The recent news flow is mixed, with growth and product-expansion catalysts offset by a material legal overhang. The most constructive developments are revenue outperformance, higher full-year revenue guidance, AI-led product initiatives, and international clinical expansion. The dominant bearish issue is FTC-related litigation and associated securities-fraud class-action claims, which have contributed to volatile trading. Past performance does not guarantee future results. Bullish developments Revenue momentum: In 2026Q2, Hims & Hers reported USD 753.214 million in sales, above the USD 699.889 million estimate; the company also r

$AMZN VERTICAL 261030 PUT 245.0/PUT 240.0$ 1️⃣ Why am I making this trade now? Bull put spread 30th Oct expiry with strike $245/240. Catching the upside momentum. The older BPS for 23rd expiry was closed on Fri and assessed the setup is still viable so opened another trade 1 week later to 30th Oct.  Since the price had moved up by at least $10 between the 2 trades, I've adjusted up the stroked by a $5 higher to short put at $245 and long put 1 strike lower.  Stock still a distance away from short term high so it the Q4 positive momentum market can carry the trade, then this can be profitable.  2️⃣ What’s my plan from here? take profit at around 70-90% max premium. Take

$ASTS 20261023 40.0 PUT$ Limit order filled during capitulation to sell ASTS cash secured put at $40 psychological support.

$INTC 20261016 96.0 PUT$ Limit order filled to sell INTC cash secured put below $100 psychological support for credit.

$INTC DIAGONAL 261012/261009 PUT 103.0/PUT 105.0$ Diagonal roll put to delay assignment by one week and lower strike plus collect credit as a bonus.

$HOOD 20261023 121.0 CALL$ Limit order filled during Hood price recovery to sell call at strike $121

$ASTS 20261016 45.0 PUT$ Limit order filled to strangle existing ASTS naked calls for credit.

$TMF CALENDAR 261023/261106 PUT 31.0/PUT 31.0$ Delay option expiry by one week and collect a little credit at the same time.

$TMF DIAGONAL 261016/261030 PUT 26.5/PUT 26.0$ Diagonal roll to lower strike and delay options expiry whilst pocketing some credit.

ARKK Investment Tracker position change: Increased position in Pacific Biosciences of California by 3,466,908 shares, the number of shares held increased 20.33% compared to the previous period and now represents 0.54% of the total position.

ARKK Investment Tracker position change: Increased position in Kratos Defense & Security Solutions by 605,730 shares, the number of shares held increased 31.06% compared to the previous period and now represents 1.04% of the total position.

ARKK Investment Tracker position change: Increased position in SoFi Technologies Inc. by 603,621 shares, the number of shares held increased 20.32% compared to the previous period and now represents 0.54% of the total position.

ARKK Investment Tracker position change: Increased position in GeneDx Holdings by 258,030 shares, the number of shares held increased 20.32% compared to the previous period and now represents 1.02% of the total position.

ARKK Investment Tracker position change: Increased position in Eli Lilly by 7,614 shares, the number of shares held increased 20.17% compared to the previous period and now represents 0.52% of the total position.

ARKK Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 7,305,018 shares, the number of shares held increased 25.69% compared to the previous period and now represents 1.48% of the total position.